purevax rcpch
boehringer ingelheim vetmedica gmbh - attenuated feline rhinotracheitis herpesvirus (fhv f2 strain), inactivated feline calicivirosis antigens (fcv 431 and g1 strains), attenuated chlamydophila felis (905 strain), attenuated feline panleucopenia virus (pli iv) - Ónæmislyf fyrir felidae, - kettir - active immunisation of cats aged eight weeks and older:• against feline viral rhinotracheitis to reduce clinical signs;• against calicivirus infection to reduce clinical signs;• against chlamydophila felis infection to reduce clinical signs;• against feline panleucopenia to prevent mortality and clinical signs. sýnt hefur verið fram á ónæmiskerfi einum viku eftir grunnbólusetningu fyrir rinotracheitis, calicivirus, chlamydophila felis og panleucopenia þætti. the duration of immunity is one year after the last re-vaccination for the chlamydiosis component, and oneyear after primary vaccination and three years after the last re-vaccination for the rhinotracheitis, calicivirosis and panleucopenia components.
purevax rcpch felv
boehringer ingelheim vetmedica gmbh - attenuated feline rhinotracheitis herpesvirus (fhv f2 strain), inactivated feline calicivirosis antigens (fcv 431 and g1 strains), attenuated feline panleucopenia virus (pli iv), felv recombinant canarypox virus (vcp97), attenuated chlamydophila felis (905 strain) - Ónæmislyf fyrir felidae, - kettir - active immunisation of cats aged 8 weeks and older:against feline viral rhinotracheitis to reduce clinical signs;against calicivirus infection to reduce clinical signs;against chlamydophila felis infection to reduce clinical signs;against feline panleucopenia to prevent mortality and clinical signs;against leukaemia to prevent persistent viraemia and clinical signs of the related disease. onsets of immunity are 1 week after primary vaccination course for rhinotracheitis, calicivirus, chlamydophila felis and panleucopenia components, and 2 weeks after primary vaccination course for feline leukaemia component. the duration of immunity is one year after the last re-vaccination for the chlamydiosis and feline leukaemia components, and one year after primary vaccination course and three years after the last re-vaccination for the rhinotracheitis, calicivirosis and panleucopenia components.
fevaxyn pentofel
zoetis belgium sa - inactivated feline rhinotracheitis virus, inactivated feline calicivirus, inactivated feline chlamydophila felis, inactivated feline leukaemia virus, inactivated feline panleukopenia virus - Ónæmisfræðilegar upplýsingar - kettir - fyrir virka bólusetningar heilbrigt að kettir níu vikur eða eldri gegn feline panleukopenia og kattarlegur hvítblæði veirur og gegn sjúkdóma í öndunarfærum af völdum kattarlegur barkabólgu veira, kattarlegur calicivirus og chlamydophila felis.
doxycyklin eql pharma tafla 100 mg
eql pharma ab - doxycyclinum inn - tafla - 100 mg
meropenem sun stungulyfs-/innrennslisstofn, lausn 1 g
sun pharmaceutical industries europe b.v. - meropenemum tríhýdrat - stungulyfs-/innrennslisstofn, lausn - 1 g
amoxicillin comp alvogen (amoxin comp) filmuhúðuð tafla 875/125 mg
alvogen ehf. - amoxicillinum tríhýdrat; potassium clavulanate - filmuhúðuð tafla - 875/125 mg
meropenem wh (meropenem w&h) stungulyfs-/innrennslisstofn, lausn 500 mg
williams & halls ehf. - meropenemum tríhýdrat - stungulyfs-/innrennslisstofn, lausn - 500 mg
spectracillin filmuhúðuð tafla 500/125 mg
williams & halls ehf. - amoxicillinum tríhýdrat; acidum clavulanicum kalíum - filmuhúðuð tafla - 500/125 mg
meropenem sun stungulyfs-/innrennslisstofn, lausn 500 mg
sun pharmaceutical industries europe b.v. - meropenemum tríhýdrat - stungulyfs-/innrennslisstofn, lausn - 500 mg
meropenem wh (meropenem w&h) stungulyfs-/innrennslisstofn, lausn 1 g
williams & halls ehf. - meropenemum tríhýdrat - stungulyfs-/innrennslisstofn, lausn - 1 g